{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:02:39Z","timestamp":1792479759166,"version":"4.5.0"},"reference-count":40,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p &lt; 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.130602","type":"journal-article","created":{"date-parts":[[2014,1,16]],"date-time":"2014-01-16T04:53:52Z","timestamp":1389848032000},"page":"325-333","source":"Crossref","is-referenced-by-count":94,"title":["Comparison of Phenotype and Outcome in Microscopic Polyangiitis Between Europe and Japan"],"prefix":"10.3899","volume":"41","author":[{"given":"Shunsuke","family":"Furuta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afzal N.","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitomo","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Nagafuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Muso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieko","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kashiwakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuo","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2014,1,15]]},"reference":[{"key":"2018112909322690000_41.2.325.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077693"},{"key":"2018112909322690000_41.2.325.2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6364262"},{"key":"2018112909322690000_41.2.325.3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-10-121"},{"key":"2018112909322690000_41.2.325.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108735"},{"key":"2018112909322690000_41.2.325.5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.24"},{"key":"2018112909322690000_41.2.325.6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker205"},{"key":"2018112909322690000_41.2.325.7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn354"},{"key":"2018112909322690000_41.2.325.8","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01461005"},{"key":"2018112909322690000_41.2.325.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.21142"},{"key":"2018112909322690000_41.2.325.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020286"},{"key":"2018112909322690000_41.2.325.11","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-10-200905190-00004"},{"key":"2018112909322690000_41.2.325.12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010090"},{"key":"2018112909322690000_41.2.325.13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","article-title":"Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study","volume":"22","author":"Ozaki","year":"2012","journal-title":"Mod Rheumatol"},{"key":"2018112909322690000_41.2.325.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370206"},{"key":"2018112909322690000_41.2.325.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715"},{"key":"2018112909322690000_41.2.325.16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00089.x"},{"key":"2018112909322690000_41.2.325.17","unstructured":"What is an intractable disease? Japan Intractable Diseases Information Center. [Internet: Accessed Nov. 12, 2013.] Available from: www.nanbyou.or.jp\/entry\/245"},{"key":"2018112909322690000_41.2.325.18","first-page":"31","article-title":"Development and validation of a disease extent index for Wegener\u2019s granulomatosis","volume":"55","author":"De Groot","year":"2001","journal-title":"Clin Nephrol"},{"key":"2018112909322690000_41.2.325.19","first-page":"671","article-title":"Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis","volume":"87","author":"Luqmani","year":"1994","journal-title":"QJM"},{"key":"2018112909322690000_41.2.325.20","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.101279"},{"key":"2018112909322690000_41.2.325.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(97)80052-0"},{"key":"2018112909322690000_41.2.325.22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.097758"},{"key":"2018112909322690000_41.2.325.23","first-page":"2488","article-title":"Current status of outcome measures in vasculitis: focus on Wegener\u2019s granulomatosis and microscopic polyangiitis. Report from OMERACT 7","volume":"32","author":"Merkel","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909322690000_41.2.325.24","unstructured":"National Institute of Population and Social Security Research (Japan) . 2010. [Internet. Accessed Nov. 12, 2013.] Available from: www.ipss.go.jp\/syoushika\/tohkei\/Popular\/Popular2012.asp?chap=0"},{"key":"2018112909322690000_41.2.325.25","unstructured":"Organisation for Economic Co-operation and Development [Internet. Accessed Dec. 11, 2013.] Available from: www.oecd.org\/els\/health-systems\/oecdhealthdata2013-frequentlyrequesteddata.htm"},{"key":"2018112909322690000_41.2.325.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep227"},{"key":"2018112909322690000_41.2.325.27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1164\/ajrccm.177.12.1397a","article-title":"Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients","volume":"177","author":"Azuma","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2018112909322690000_41.2.325.28","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e32833f1987"},{"key":"2018112909322690000_41.2.325.29","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010050477"},{"key":"2018112909322690000_41.2.325.30","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-012-0755-7"},{"key":"2018112909322690000_41.2.325.31","doi-asserted-by":"publisher","DOI":"10.1002\/art.11115"},{"key":"2018112909322690000_41.2.325.32","doi-asserted-by":"publisher","DOI":"10.1002\/art.20928"},{"key":"2018112909322690000_41.2.325.33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep304"},{"key":"2018112909322690000_41.2.325.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.2008.01672.x"},{"key":"2018112909322690000_41.2.325.35","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.034215"},{"key":"2018112909322690000_41.2.325.36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker112"},{"key":"2018112909322690000_41.2.325.37","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.7727"},{"key":"2018112909322690000_41.2.325.38","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-012-0598-2"},{"key":"2018112909322690000_41.2.325.39","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201750"},{"key":"2018112909322690000_41.2.325.40","doi-asserted-by":"publisher","DOI":"10.1002\/art.34562"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.130602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:33:34Z","timestamp":1543516414000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.130602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,15]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,1]]},"published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.3899\/jrheum.130602"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.130602","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,15]]}}}